-
1
-
-
7244250314
-
Antibiotics: A shot in the arm
-
Leeb, M. Antibiotics: a shot in the arm. Nature 2004, 431, 892-893.
-
(2004)
Nature
, vol.431
, pp. 892-893
-
-
Leeb, M.1
-
2
-
-
7244245763
-
Antibiotics at the crossroads
-
Nathan, C. Antibiotics at the crossroads. Nature 2004, 431, 899-902.
-
(2004)
Nature
, vol.431
, pp. 899-902
-
-
Nathan, C.1
-
3
-
-
3042782938
-
The MEP pathway: A new target for the development of herbicides, antibiotics and antimalarial drugs
-
(a) Rodriguez-Concepcion, M. The MEP pathway: a new target for the development of herbicides, antibiotics and antimalarial drugs. Curr. Pharm. Des. 2004, 10, 2391-2400.
-
(2004)
Curr. Pharm. Des.
, vol.10
, pp. 2391-2400
-
-
Rodriguez-Concepcion, M.1
-
4
-
-
0041589189
-
The methylerythritol phosphate pathway and its significance as a novel drug target
-
(b) Testa, C. A.; Brown, M. J. The methylerythritol phosphate pathway and its significance as a novel drug target. Curr. Pharm. Biotechnol. 2003, 4, 248-259.
-
(2003)
Curr. Pharm. Biotechnol.
, vol.4
, pp. 248-259
-
-
Testa, C.A.1
Brown, M.J.2
-
5
-
-
0019256502
-
In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic
-
Mine, Y.; Kamimura, T.; Nonoyama, S.; Nishida, M.; Goto, S.; Kuwahara, S. In vitro and in vivo antibacterial activities of FR-31564, a new phosphonic acid antibiotic. J. Antibiot. (Tokyo) 1980, 33, 36-43.
-
(1980)
J. Antibiot. (Tokyo)
, vol.33
, pp. 36-43
-
-
Mine, Y.1
Kamimura, T.2
Nonoyama, S.3
Nishida, M.4
Goto, S.5
Kuwahara, S.6
-
6
-
-
0032558613
-
Fosmidomycin, a specific inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis
-
Kuzuyama, T.; Shimizu, T.; Takahashi, S.; Seto, H. Fosmidomycin, a specific inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in the nonmevalonate pathway for terpenoid biosynthesis. Tetrahedron Lett. 1998, 39, 7913-7916.
-
(1998)
Tetrahedron Lett.
, vol.39
, pp. 7913-7916
-
-
Kuzuyama, T.1
Shimizu, T.2
Takahashi, S.3
Seto, H.4
-
7
-
-
0033520336
-
Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs
-
DOI 10.1126/science.285.5433.1573
-
(a) Jomaa, H.; Wiesner, J.; Sanderbrand, S.; Altincicek, B.; Weidemeyer, C.; Hintz, M.; Turbachova, I.; Eberl, M.; Zeidler, J.; Lichtenthaler, H. K.; Soldati, D.; Beck, E. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs. Science 1999, 285, 1573-1576. (Pubitemid 29420582)
-
(1999)
Science
, vol.285
, Issue.5433
, pp. 1573-1576
-
-
Jomaa, H.1
Wiesner, J.2
Sanderbrand, S.3
Altincicek, B.4
Weidemeyer, C.5
Hintz, M.6
Turbachova, I.7
Eberl, M.8
Zeidler, J.9
Lichtenthaler, H.K.10
Soldati, D.11
Beck, E.12
-
8
-
-
0037079323
-
Fosmidomycin for malaria
-
(b) Missinou, M. A.; Borrmann, S.; Schindler, A.; Issifou, S.; Adegnika, A. A.; Matsiegui, P. B.; Binder, R.; Lell, B.; Wiesner, J.; Baranek, T.; Jomaa, H.; Kremsner, P. G. Fosmidomycin for malaria. Lancet 2002, 360, 1941-1942.
-
(2002)
Lancet
, vol.360
, pp. 1941-1942
-
-
Missinou, M.A.1
Borrmann, S.2
Schindler, A.3
Issifou, S.4
Adegnika, A.A.5
Matsiegui, P.B.6
Binder, R.7
Lell, B.8
Wiesner, J.9
Baranek, T.10
Jomaa, H.11
Kremsner, P.G.12
-
9
-
-
28844484972
-
1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: Towards understanding mycobacterial resistance to fosmidomycin
-
(a) Dhiman, R. K.; Schaeffer, M. L.; Bailey, A. M.; Testa, C. A.; Scherman, H.; Crick, D. C. 1-Deoxy-D-xylulose 5-phosphate reductoisomerase (IspC) from Mycobacterium tuberculosis: towards understanding mycobacterial resistance to fosmidomycin. J. Bacteriol. 2005, 187, 8395-8402.
-
(2005)
J. Bacteriol.
, vol.187
, pp. 8395-8402
-
-
Dhiman, R.K.1
Schaeffer, M.L.2
Bailey, A.M.3
Testa, C.A.4
Scherman, H.5
Crick, D.C.6
-
10
-
-
44849135047
-
Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake
-
DOI 10.1186/1471-2180-8-78
-
(b) Brown, A. C.; Parish, T. DXR is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake. BMC Microbiol. 2008, 8, 78-86. (Pubitemid 351793258)
-
(2008)
BMC Microbiology
, vol.8
, pp. 78
-
-
Brown, A.C.1
Parish, T.2
-
11
-
-
48249107154
-
Evaluation of in vitro antibacterial activity of fosmidomycin and its derivatives
-
For development based on fosmidomycin, see the following: (a)
-
For development based on fosmidomycin, see the following: (a) Shtannikov, A. V.; Sergeeva, E. E.; Biketov, S. F.; Ostrovskii, D. N. Evaluation of in vitro antibacterial activity of fosmidomycin and its derivatives. Antibiot. Khimioter. 2007, 52, 3-9.
-
(2007)
Antibiot. Khimioter.
, vol.52
, pp. 3-9
-
-
Shtannikov, A.V.1
Sergeeva, E.E.2
Biketov, S.F.3
Ostrovskii, D.N.4
-
12
-
-
14244257854
-
Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: Phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase
-
DOI 10.1042/BJ20041378
-
(b) Kuntz, L.; Tritsch, D.; Grosdemange-Billiard, C.; Hemmerlin, A.; Willem, A.; Bach, T. J.; Rohmer, M. Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase. Biochem. J. 2005, 386, 127-135. (Pubitemid 40289232)
-
(2005)
Biochemical Journal
, vol.386
, Issue.1
, pp. 127-135
-
-
Kuntz, L.1
Tritsch, D.2
Grosdemange-Billiard, C.3
Hemmerlin, A.4
Willem, A.5
Bach, T.J.6
Rohmer, M.7
-
13
-
-
26944489968
-
A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase
-
(c) Merckle, L.; de Andres-Gomez, A.; Dick, B.; Cox, R. J.; Godfrey, C. R. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose- 5-phosphate reductoisomerase. ChemBioChem 2005, 6, 1866-1874.
-
(2005)
ChemBioChem
, vol.6
, pp. 1866-1874
-
-
Merckle, L.1
De Andres-Gomez, A.2
Dick, B.3
Cox, R.J.4
Godfrey, C.R.5
-
14
-
-
43549115217
-
Synthesis and analysis of a fluorinated product analogue as an inhibitor for 1-deoxy-D-xylulose 5-phosphate reductoisomerase
-
(d) Munos, J. W.; Pu, X.; Liu, H. W. Synthesis and analysis of a fluorinated product analogue as an inhibitor for 1-deoxy-D-xylulose 5-phosphate reductoisomerase. Bioorg. Med. Chem. Lett. 2008, 18, 3090-3094.
-
(2008)
Bioorg. Med. Chem. Lett.
, vol.18
, pp. 3090-3094
-
-
Munos, J.W.1
Pu, X.2
Liu, H.W.3
-
15
-
-
34748895608
-
Novel deoxyxylulosephosphate-reductoisomerase inhibitors: Fosmidomycin derivatives with spacious acyl residues
-
(e) Ortmann, R.; Wiesner, J.; Silber, K.; Klebe, G.; Jomaa, H.; Schlitzer, M. Novel deoxyxylulosephosphate-reductoisomerase inhibitors: fosmidomycin derivatives with spacious acyl residues. Arch. Pharm. (Weinheim, Ger.) 2007, 340, 483-490.
-
(2007)
Arch. Pharm. (Weinheim, Ger.)
, vol.340
, pp. 483-490
-
-
Ortmann, R.1
Wiesner, J.2
Silber, K.3
Klebe, G.4
Jomaa, H.5
Schlitzer, M.6
-
16
-
-
18744377281
-
AFMoC enhances predictivity of 3D QSAR: A case study with DOXP-reductoisomerase
-
(f) Silber, K.; Heidler, P.; Kurz, T.; Klebe, G. AFMoC enhances predictivity of 3D QSAR: a case study with DOXP-reductoisomerase. J. Med. Chem. 2005, 48, 3547-3563.
-
(2005)
J. Med. Chem.
, vol.48
, pp. 3547-3563
-
-
Silber, K.1
Heidler, P.2
Kurz, T.3
Klebe, G.4
-
17
-
-
32844461335
-
Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase
-
(g) Woo, Y. H.; Fernandes, R. P.; Proteau, P. J. Evaluation of fosmidomycin analogs as inhibitors of the Synechocystis sp. PCC6803 1-deoxy-D-xylulose 5-phosphate reductoisomerase. Bioorg. Med. Chem. 2006, 14, 2375-2385.
-
(2006)
Bioorg. Med. Chem.
, vol.14
, pp. 2375-2385
-
-
Woo, Y.H.1
Fernandes, R.P.2
Proteau, P.J.3
-
18
-
-
33745178164
-
Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of fosmidomycin and FR900098
-
(h) Kurz, T.; Schlüter, K.; Kaula, U.; Bergmann, B.; Walter, R. D.; Geffken, D. Synthesis and antimalarial activity of chain substituted pivaloyloxymethyl ester analogues of fosmidomycin and FR900098. Bioorg. Med. Chem. 2006, 14, 5121-5135.
-
(2006)
Bioorg. Med. Chem.
, vol.14
, pp. 5121-5135
-
-
Kurz, T.1
Schlüter, K.2
Kaula, U.3
Bergmann, B.4
Walter, R.D.5
Geffken, D.6
-
19
-
-
34547161878
-
Conformationally restrained aromatic analogues of fosmidomycin and FR900098
-
(i) Kurz, T.; Schlüter, K.; Pein, M.; Behrendt, C.; Bergmann, B.; Walter, R. D. Conformationally restrained aromatic analogues of fosmidomycin and FR900098. Arch. Pharm. Chem. Life Sci. 2007, 340, 339-344.
-
(2007)
Arch. Pharm. Chem. Life Sci.
, vol.340
, pp. 339-344
-
-
Kurz, T.1
Schlüter, K.2
Pein, M.3
Behrendt, C.4
Bergmann, B.5
Walter, R.D.6
-
20
-
-
33144477580
-
Synthesis of R-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors
-
(j) Haemers, T.; Wiesner, J.; Van Poecke, S.; Goeman, J.; Henschker, D.; Beck, E.; Jomaa, H.; Van Calenbergh, S. Synthesis of R-substituted fosmidomycin analogues as highly potent Plasmodium falciparum growth inhibitors. Bioorg. Med. Chem. Lett. 2006, 16, 1888-1891.
-
(2006)
Bioorg. Med. Chem. Lett.
, vol.16
, pp. 1888-1891
-
-
Haemers, T.1
Wiesner, J.2
Van Poecke, S.3
Goeman, J.4
Henschker, D.5
Beck, E.6
Jomaa, H.7
Van Calenbergh, S.8
-
21
-
-
34248532764
-
Divergent strategy for the synthesis of α-aryl-substituted fosmidomycin analogues
-
(k) Devreux, V.; Wiesner, J.; Jomaa, H.; Rozenski, J.; Van der Eycken, J.; Van Calenbergh, S. Divergent strategy for the synthesis of α-aryl-substituted fosmidomycin analogues. J. Org. Chem. 2007, 72, 3783-3789.
-
(2007)
J. Org. Chem.
, vol.72
, pp. 3783-3789
-
-
Devreux, V.1
Wiesner, J.2
Jomaa, H.3
Rozenski, J.4
Van Der Eycken, J.5
Van Calenbergh, S.6
-
22
-
-
4444236556
-
Crystallographic structures of two bisphosphonate:1-deoxyxylulose-5- phosphate reductoisomerase complexes
-
For non-fosmidomycin-like inhibitors, see the following: (l)
-
For non-fosmidomycin-like inhibitors, see the following: (l) Yajima, S.; Hara, K.; Sanders, J. M.; Yin, F.; Ohsawa, K.; Wiesner, J.; Jomaa, H.; Oldfield, E. Crystallographic structures of two bisphosphonate:1-deoxyxylulose-5- phosphate reductoisomerase complexes. J. Am. Chem. Soc. 2004, 126, 10824-10825.
-
(2004)
J. Am. Chem. Soc.
, vol.126
, pp. 10824-10825
-
-
Yajima, S.1
Hara, K.2
Sanders, J.M.3
Yin, F.4
Ohsawa, K.5
Wiesner, J.6
Jomaa, H.7
Oldfield, E.8
-
23
-
-
0042064058
-
High-throughput screen for inhibitors of 1-deoxy-D-xylulose 5-phosphate reductoisomerase by surrogate ligand competition
-
For high-throughput screening, see the following: (m)
-
For high-throughput screening, see the following: (m) Gottlin, E. B.; Benson, R. E.; Conary, S.; Antonio, B.; Duke, K.; Payne, E. S.; Ashraf, S. S.; Christensen, D. J. High-throughput screen for inhibitors of 1-deoxy-D-xylulose 5-phosphate reductoisomerase by surrogate ligand competition. J. Biomol. Screening 2003, 8, 332-339.
-
(2003)
J. Biomol. Screening
, vol.8
, pp. 332-339
-
-
Gottlin, E.B.1
Benson, R.E.2
Conary, S.3
Antonio, B.4
Duke, K.5
Payne, E.S.6
Ashraf, S.S.7
Christensen, D.J.8
-
24
-
-
34249940474
-
Structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in a quaternary complex with a magnesium ion, NADPH and the antimalarial drug fosmidomycin
-
DOI 10.1107/S1744309107024475, PII S1744309107024475
-
Yajima, S.; Hara, K.; Iino, D.; Sasaki, Y.; Kuzuyama, T.; Ohsawa, K.; Seto, H. Structure of 1-deoxy-D-xylulose 5-phosphate reductoisomerase in a quaternary complex with a magnesium ion, NADPH and the antimalarial drug fosmidomycin. Acta Crystallogr., Sect. F 2007, 63, 466-470. (Pubitemid 46878873)
-
(2007)
Acta Crystallographica Section F: Structural Biology and Crystallization Communications
, vol.63
, Issue.6
, pp. 466-470
-
-
Yajima, S.1
Hara, K.2
Iino, D.3
Sasaki, Y.4
Kuzuyama, T.5
Ohsawa, K.6
Seto, H.7
-
25
-
-
9644301008
-
The crystal structure of E. coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation
-
MacSweeney, A.; Lange, R.; Fernandes, R. P.; Schulz, H.; Dale, G. E.; Douangamath, A.; Proteau, P. J.; Oefner, C. The crystal structure of E. coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation. J. Mol. Biol. 2005, 345, 115-127.
-
(2005)
J. Mol. Biol.
, vol.345
, pp. 115-127
-
-
MacSweeney, A.1
Lange, R.2
Fernandes, R.P.3
Schulz, H.4
Dale, G.E.5
Douangamath, A.6
Proteau, P.J.7
Oefner, C.8
-
26
-
-
49949138005
-
Solution stability constants of some metal complexes of derivatives of catechol
-
Athavale, V. T.; Prabhu, L. H.; Vartak, D. G. Solution stability constants of some metal complexes of derivatives of catechol. J. Inorg. Nucl. Chem. 1966, 28, 1237-1249.
-
(1966)
J. Inorg. Nucl. Chem.
, vol.28
, pp. 1237-1249
-
-
Athavale, V.T.1
Prabhu, L.H.2
Vartak, D.G.3
-
27
-
-
0011283177
-
Theomodynamic metal-ligand stability constants of alkali eath metals with N-p-chlorophenylbenzohydroxamic acid
-
Agrawal, Y. K.; Roshania, R. D. Theomodynamic metal-ligand stability constants of alkali eath metals with N-p-chlorophenylbenzohydroxamic acid. Z. Phys. Chem. (Leipzig) 1982, 263, 822-826.
-
(1982)
Z. Phys. Chem. (Leipzig)
, vol.263
, pp. 822-826
-
-
Agrawal, Y.K.1
Roshania, R.D.2
-
28
-
-
71049114346
-
-
www.schrodinger.com.
-
-
-
-
29
-
-
4444341426
-
The evolution of the matrix metalloproteinase inhibitor drug discovery program at abbott laboratories
-
For hydroxamate based matrix metalloproteinase inhibitors, see the following: (a)
-
For hydroxamate based matrix metalloproteinase inhibitors, see the following: (a) Wada, C. K. The evolution of the matrix metalloproteinase inhibitor drug discovery program at abbott laboratories. Curr. Top. Med. Chem. 2004, 4, 1255-1267.
-
(2004)
Curr. Top. Med. Chem.
, vol.4
, pp. 1255-1267
-
-
Wada, C.K.1
-
30
-
-
4644314055
-
Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin A after intraperitoneal administration to mice
-
For hydroxamate based histone deacetylase inhibitors, see the following: (b)
-
For hydroxamate based histone deacetylase inhibitors, see the following: (b) Sanderson, L.; Taylor, G. W.; Aboagye, E. O.; Alao, J. P.; Latigo, J. R.; Coombes, R. C.; Vigushin, D. M. Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin A after intraperitoneal administration to mice. Drug Metab. Dispos. 2004, 32, 1132-1138.
-
(2004)
Drug Metab. Dispos.
, vol.32
, pp. 1132-1138
-
-
Sanderson, L.1
Taylor, G.W.2
Aboagye, E.O.3
Alao, J.P.4
Latigo, J.R.5
Coombes, R.C.6
Vigushin, D.M.7
-
31
-
-
34047168930
-
The design of inhibitors for medicinally relevant metalloproteins
-
(a) Jacobsen, F. E.; Lewis, J. A.; Cohen, S. M. The design of inhibitors for medicinally relevant metalloproteins. ChemMedChem 2007, 2, 152-171.
-
(2007)
ChemMedChem
, vol.2
, pp. 152-171
-
-
Jacobsen, F.E.1
Lewis, J.A.2
Cohen, S.M.3
-
32
-
-
33644944087
-
A new role for old ligands: Discerning chelators for zinc metalloproteinases
-
(b) Jacobsen, F. E.; Lewis, J. A.; Cohen, S. M. A new role for old ligands: discerning chelators for zinc metalloproteinases. J. Am. Chem. Soc. 2006, 128, 3156-3157.
-
(2006)
J. Am. Chem. Soc.
, vol.128
, pp. 3156-3157
-
-
Jacobsen, F.E.1
Lewis, J.A.2
Cohen, S.M.3
-
33
-
-
71049189705
-
-
See Supporting Information for detailed synthesis and references
-
See Supporting Information for detailed synthesis and references.
-
-
-
|